Treatment switch to nonacog beta pegol factor IX in hemophilia B: A Canadian cost-consequence analysis based on real-world factor IX consumption and clinical outcomes
Titel:
Treatment switch to nonacog beta pegol factor IX in hemophilia B: A Canadian cost-consequence analysis based on real-world factor IX consumption and clinical outcomes
Auteur:
Iorio, Alfonso MacDonald, Vance Caillaud, Alexandre Luckevich, Maria D. Christoffersen, Pia Matino, Davide Keepanasseril, Arun Iserman, Emma Germini, Federico Bentley, Anthony Poon, Man-Chiu
Verschenen in:
Research and practice in thrombosis and haemostasis